|
|
|
|
Changes in Intrahepatic, Endogenous Interferon Expression in Chronic HCV, Genotype-1 Patients Treated with Interferon-free, Ribavirin-Free DAA Regimens
|
|
|
Reported by Jules Levin
NY AASLD/EASL Special Conference Sept 2014
Eric G. Meissner1,2, Anita Kohli1,3, Amy Nelson1, Zayani Sims4, John McHutchison5, Henry Masur4, Shyam Kottilil1,6.
1. Laboratory of Immunoregulation/NIAID/NIH, Bethesda, MD.
2. Division of Infectious Diseases, Medical University of South Carolina, Charleston, SC.
3. Clinical Research Directorate/CMRP, SAIC-Frederick, Inc., Frederick, MD.
4. Critical Care Medicine Department/NIH, Bethesda, MD.
5. Gilead Sciences, Foster City, CA.
6. Institute of Human Virology, University of Maryland Medical School, Baltimore, MD.
|
|
|
|
|
|
|